Massachusetts (population 7.1M, Boston) is the second-largest biotech and life sciences hub in the US after California, generating $20B+ in annual healthcare sector revenue. State economy centered on healthcare, higher education, and technology; recent signal activity shows domestic investment expansion by Novartis and related firms, alongside tobacco regulation policy debate and energy pricing pressures ahead of Memorial Day travel.
Full PSI intelligence, network analysis, EDGAR filings, and predicted links require an access token.
Notes, edits, or content requests — sent directly to James.